Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Applied and Environmental Microbiology

• Publication date

  2011-11-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AEM.05741-11PMID 22113912PMCID PMC3264097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

  2009cited by this paper
• Recombineering: a homologous recombination-based method of genetic engineering

  2009cited by this paper
• A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy

  2009cited by this paper
• Use of rpsL as a Counterselectable Marker in Borrelia burgdorferi

  2009cited by this paper
• Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances

  2008cited by this paper
• The bacterial response to the chalcogen metalloids Se and Te.

  2008cited by this paper
• A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity

  2007cited by this paper
• Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by denaturing HPLC analysis and DNA sequencing.

  2007cited by this paper
• FDA approves use of bacteriophages to be added to meat and poultry products.

  2006influential reference
• Efficient and seamless DNA recombineering using a thymidylate synthase A selection system in Escherichia coli

  2005cited by this paper
• Phage therapy: the Escherichia coli experience.

  2005cited by this paper
• Antibacterial resistance worldwide: causes, challenges and responses

  2004cited by this paper
• Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections

  2003cited by this paper
• The prospect for bacteriophage therapy in Western medicine

  2003cited by this paper
• An rpsL Cassette, Janus, for Gene Replacement through Negative Selection in Streptococcus pneumoniae

  2001cited by this paper
• Characterization of gram-positive tellurite resistance encoded by the Streptococcus pneumoniae tehB gene.

  1999cited by this paper
• Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities

  1996cited by this paper
• Mutant sequences in the rpsL gene of Escherichia coli B/r: Mechanistic implications for spontaneous and ultraviolet light mutagenesis

  1992cited by this paper
• Broad-host-range gyrase A gene probe

  1990cited by this paper
• Homologous recombination in Escherichia coli: dependence on substrate length and homology.

  1986cited by this paper
• ULTRAVIOLET SENSITIVITY OF ESCHERICHIA COLI CONTAINING HEAT-INDUCIBLE LAMBDA PROPHAGES.

  1964cited by this paper
• Ultraviolet Sensitivity of Escherichia coli Containing Heat-Inducible λ Prophages

  1964cited by this paper
• STREPTOMYCIN RESISTANCE: A GENETICALLY RECESSIVE MUTATION

  1951cited by this paper
• Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page

  year unknowncited by this paper

• Synthetic Biology of Plants and Microbes for Agriculture, Environment, and Future Applications

  2026cites this paper
• Management of Diabetic Foot Infections Using Phage Therapy

  2026cites this paper
• Revisiting therapeutic options against resistant klebsiella pneumoniae infection: Phage therapy is key.

  2025cites this paper
• Advanced Strategies in Phage Research: Innovations, Applications, and Challenges

  2025cites this paper
• CRISPR–Cas therapies targeting bacteria

  2025cites this paper
• Effects of bacteriophages on gut microbiome functionality

  2025cites this paper
• Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model

  2025cites this paper
• Hotspots of genetic change in Yersinia pestis

  2025cites this paper
• CRISPR-Cas10-Assisted Structural Modification of Staphylococcal Kayvirus for Imaging and Biosensing Applications

  2025cites this paper
• Armed Phages: A New Weapon in the Battle Against Antimicrobial Resistance

  2025cites this paper
• Isolation of Pseudomonas aeruginosa Phages vB_Psu_NEU2023 and vB_Psu_NEU2024 Leads to the Establishment of a New Genus, Alasiavirus

  2025cites this paper
• Engineering bacteriophages for targeted superbug eradication

  2025cites this paper
• Unravelling the advances of CRISPR-Cas9 as a precise antimicrobial therapy: a systematic review.

  2025cites this paper
• Simple theoretical models predict some - but not all – aspects of the experimental evolution of antibiotic resistance

  2025cites this paper
• Disarming Salmonella virulence with 32H-hilE anti-virulence bacteriophage.

  2025cites this paper
• The virulent bacteriophage Henu8 as an antimicrobial synergist against Escherichia coli

  2025cites this paper
• Beyond Antibiotics: Exploring the Potential of Bacteriophages and Phage Therapy

  2024cites this paper
• Bacteriophages: a potential game changer in food processing industry

  2024cites this paper
• Benefits and Challenges of Applying Bacteriophage Biocontrol in the Consumer Water Cycle

  2024cites this paper
• Characterization of two lytic bacteriophages infecting carbapenem-resistant clinical Klebsiella pneumoniae in Dhaka, Bangladesh

  2024cites this paper
• A Comprehensive Review on Phage Therapy and Phage-Based Drug Development

  2024cites this paper
• Advances in bacteriophage-mediated strategies for combating polymicrobial biofilms

  2024cites this paper
• The Potential of Phage Treatment to Inactivate Planktonic and Biofilm-Forming Pseudomonas aeruginosa

  2024cites this paper
• The rise, fall, and resurgence of phage therapy for urinary tract infection

  2024cites this paper
• Current Knowledge and Perspectives of Phage Therapy for Combating Refractory Wound Infections

  2024cites this paper
• Mathematical comparison of protocols for adapting a bacteriophage to a new host

  2024cites this paper
• Genomic and taxonomic evaluation of 38 Treponema prophage sequences

  2024cites this paper
• Bacteriophage–Host Interactions and the Therapeutic Potential of Bacteriophages

  2024cites this paper
• Bacteriophage Production in Compliance with Regulatory Requirements.

  2024cites this paper
• Engineering Phages to Fight Multidrug-Resistant Bacteria

  2024cites this paper
• Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans.

  2024cites this paper
• Encapsulated Phage Cocktail: The Destined Environmental Biocontrol Agent For Pathogenic Leptospira

  2024cites this paper
• Efficacy of Bacteriophages in Wound Healing: An Updated Review

  2024cites this paper
• Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment

  2023cites this paper
• Clinically relevant antibiotic resistance genes are linked to a limited set of taxa within gut microbiome worldwide

  2023cites this paper
• Role of Virus on Oral Biofilm: Inducer or Eradicator?

  2023cites this paper
• Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy

  2023cites this paper
• Therapeutics and prophylactic efficacy of novel lytic Escherichia phage vB_EcoS_PJ16 against multidrug-resistant avian pathogenic E. coli using in vivo study

  2023cites this paper
• Characterization of a novel phage vB_Pae_HB2107-3I that infects Pseudomonas aeruginosa

  2023cites this paper
• Disarm The Bacteria: What Temperate Phages Can Do

  2023cites this paper
• Engineering the gut microbiome

  2023cites this paper
• The Biotechnological Application of Bacteriophages: What to Do and Where to Go in the Middle of the Post-Antibiotic Era

  2023cites this paper
• The spread of antibiotic resistance to humans and potential protection strategies.

  2023cites this paper
• Bacteriophages as Biotechnological Tools

  2023cites this paper
• A critical review of novel antibiotic resistance prevention approaches with a focus on postbiotics

  2023cites this paper
• An efficient, scarless, selection-free technology for phage engineering

  2023influential citation
• Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans

  2023cites this paper
• Paving the way forward: Escherichia coli bacteriophages in a One Health approach

  2023cites this paper
• Genetic engineering of bacteriophages: Key concepts, strategies, and applications.

  2023cites this paper
• Characterization of Klebsiella pneumoniae bacteriophages, KP1 and KP12, with deep learning-based structure prediction

  2023cites this paper
• Advancements in bacteriophage therapies and delivery for bacterial infection

  2023cites this paper
• Applications of designer phage encoding recombinant gene payloads.

  2023cites this paper
• The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects.

  2022cites this paper
• Bacteriophage therapy in aquaculture: current status and future challenges

  2022cites this paper
• Grand challenge of antibiotics resistance: A global, multidisciplinary effort is needed

  2022cites this paper
• Synthetic Biology Tools for Engineering Microbial Cells to Fight Superbugs

  2022cites this paper
• Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future

  2022cites this paper
• Advances in engineering of bacteriophages for therapeutic applications

  2022cites this paper
• Rehabilitation of a misbehaving microbiome: phages for the remodeling of bacterial composition and function

  2022influential citation
• The antagonistic interactions between a polyvalent phage SaP7 and β-lactam antibiotics on combined therapies.

  2022cites this paper
• Protein Cages: From Fundamentals to Advanced Applications.

  2022cites this paper
• Approaches for bacteriophage genome engineering.

  2022cites this paper
• Infectious Diseases Impact on Biomedical Devices and Materials

  2022cites this paper
• Bacteriophage–Ciprofloxacin Combination Effectiveness Depends on Staphylococcus aureus–Candida albicans Dual-Species Communities’ Growth Model

  2022cites this paper
• Phage therapy as a protective tool against pathogenic bacteria: How far we are?

  2022cites this paper
• Phage Therapy

  2021cites this paper
• A combination therapy of Phages and Antibiotics: Two is better than one

  2021cites this paper
• Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?

  2021influential citation
• The Many Applications of Engineered Bacteriophages—An Overview

  2021cites this paper
• Uses of Bacteriophages as Bacterial Control Tools and Environmental Safety Indicators

  2021cites this paper
• Engineering therapeutic phages for enhanced antibacterial efficacy.

  2021cites this paper
• Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future

  2021cites this paper
• Advances in bacteriophage-mediated control strategies to reduce bacterial virulence

  2021cites this paper
• Addressing Antimicrobial Resistance Through Nanoantibiotics

  2021cites this paper
• The Future of Virology is Synthetic

  2021cites this paper
• Phage Therapy in Cystic Fibrosis. Challenges and Perspectives

  2020cites this paper
• Machine-Learning Single-Stranded DNA Nanoparticles for Bacterial Analysis.

  2020cites this paper
• Engineering Bacteria to Produce Pure Phage-like Particles for Gene Delivery.

  2020cites this paper
• Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infections

  2020cites this paper
• Phage therapy efficacy: a review of the last 10 years of preclinical studies

  2020cites this paper
• An exegesis of bacteriophage therapy: An emerging player in the fight against anti-microbial resistance

  2020cites this paper
• Alternative therapeutic approaches in the era of antimicrobial resistance: An overview

  2020cites this paper
• Engineered Bacteriophages for Practical Applications.

  2020cites this paper
• Biocommunication of Phages

  2020cites this paper
• Antibiotic Resistance in Soil

  2020cites this paper
• Bacteriophages as drivers of bacterial virulence and their potential for biotechnological exploitation.

  2020cites this paper
• Phage Therapy in Gastrointestinal Diseases

  2020cites this paper
• Current challenges and future opportunities of phage therapy.

  2020cites this paper
• Genetic manipulation of phages for therapy using BRED.

  2020cites this paper
• Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry

  2020cites this paper
• Biochemical Characterization of Diamide Inhibitors with N-acetylglucosaminidases LytG from Bacillus subtilis

  2020cites this paper
• Molecular and Evolutionary Determinants of Bacteriophage Host Range.

  2019cites this paper
• Exploitation du potentiel des bactériophages dans le traitement des surfaces en contact avec l'eau, contaminées par un biofilm de P. aeruginosa

  2019cites this paper
• Human Virome and Disease: High-Throughput Sequencing for Virus Discovery, Identification of Phage-Bacteria Dysbiosis and Development of Therapeutic Approaches with Emphasis on the Human Gut

  2019cites this paper
• Engineered bacteriophages as programmable biocontrol agents

  2019cites this paper
• BioBits Health: Classroom Activities Exploring Engineering, Biology, and Human Health with Fluorescent Readouts.

  2019cites this paper
• Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages

  2019cites this paper
• Efficacy and potential of phage therapy against multidrug resistant Shigella spp.

  2019cites this paper
• Microscopic Saviors: The Use of Phages in Medicine

  2019cites this paper
• Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance.

  2019cites this paper